Results
1 -
10 of
136
(Click
here to explore results)
- Allosterism in Drug Discovery, CHAPTER 14 Development of AMPA Receptor Modulators as Cognition Enhancers. Craig Jamieson, Emma L. Duffy
, 2017
, Pages 310-333
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 10 Glutamate Receptor Modulators as Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease. Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli, Ian J. Reynolds
, 2013
, Pages 237-265
- Ion Channel Drug Discovery, CHAPTER 6 AMPA Receptor Positive Allosteric Modulators – a Case History. Simon E Ward
, 2015
, Pages 105-134
- G Protein-Coupled Receptors: From Structure to Function, Chapter 13 Functional Crosstalk between Group I Metabotropic Glutamate Receptors and Ionotropic Glutamate Receptors Controls Synaptic Transmission. Joel Bockaert, Laurent Fagni, Julie Perroy
, 2011
, Pages 269-283
- Drug Discovery for Psychiatric Disorders, CHAPTER 4 Glutamatergic Approaches for the Treatment of Schizophrenia. John A. Morrow, Robert Gilfillan, Stuart A. Neale
, 2012
, Pages 56-98
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders. Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley
, 2012
, Pages 258-275
- Unravelling Single Cell Genomics: Micro and Nanotools, Chapter 9 Gene Analysis of Single Cells. Bruno Cauli, Bertrand Lambolez
, 2010
, Pages 81-92
- Computational Biophysics of Membrane Proteins, Chapter 8 Computational Studies of Receptors. Maria Musgaard, Philip C. Biggin
, 2017
, Pages 237-258
- Drug Discovery for Schizophrenia, CHAPTER 6 Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia. Catharine A. Mielnik, Amy J. Ramsey
, 2015
, Pages 115-140
- Drug Discovery for Psychiatric Disorders, CHAPTER 5 Discovery and Clinical Data for a Novel AMPA Receptor Positive Modulator. Simon E. Ward
, 2012
, Pages 99-122